

ACR24 - PSORIATIC ARTHRITIS
Nov 22, 2024
Catherine Bakewell, a seasoned rheumatologist and ultrasound expert, Philip Meese, a dedicated researcher on bimekizumab, and Artie Kavanaugh, an insightful rheumatologist reporting on ACR updates, dive into cutting-edge topics. They discuss the promising results of bimekizumab in alleviating pain and fatigue in psoriatic arthritis. Insights into the implications of weight loss drugs on treatment outcomes are explored, alongside crucial findings on sex differences affecting disease impact, driving home the need for tailored strategies in patient care.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Intro
00:00 • 4min
Managing Psoriatic Arthritis: Insights on Apremilast
03:48 • 5min
Advancements in Psoriatic Arthritis Research
08:33 • 22min
Advancements in Musculoskeletal Ultrasound Guidelines
30:24 • 6min
New Insights on Psoriatic Arthritis from ACR 2024
35:59 • 7min
Examining Sex Differences in Psoriatic Arthritis
43:04 • 15min
Exploring IL-17 Therapies: Efficacy on Enthesitis
57:40 • 2min